Home Actinium Completes Technology Transfer For Manufacturing Of Its Lead Drug Candidate Iomab-B
 

Keywords :   


Actinium Completes Technology Transfer For Manufacturing Of Its Lead Drug Candidate Iomab-B

2013-12-30 05:54:18| drugdiscoveryonline Home Page

Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, has successfully transferred the technology for the manufacture of Iomab-B (BC8-I-131), a drug being developed for therapeutic treatment of incurable blood cancers

Tags: technology lead transfer drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »